SCI Ventures
SCI Ventures is a venture capital firm based in Baltimore, Maryland, established in 1972. The firm focuses on investing in early-stage companies primarily within the information technology, media, and telecommunications sectors. A significant aspect of SCI Ventures' mission is to support minority and women entrepreneurs in emerging domestic markets, which have historically been underfunded yet hold strong potential for innovation and growth. By concentrating on these underserved areas, SCI Ventures aims to create a competitive advantage in a dynamic business landscape, enabling both investors and entrepreneurs to capitalize on new opportunities. The firm emphasizes deploying capital in fragmented and evolving industries, thereby fostering sustainable development and positive economic impact.
2 past transactions
Axonis Therapeutics
Series A in 2024
Axonis Therapeutics is a biotechnology company focused on neurological disorders. It develops medicines targeting KCC2, a critical mediator of inhibition within the brain, using a proprietary neuron-specific K-Cl cotransporter (KCC2) discovery engine. The company aims to improve lives by treating conditions such as epilepsy and pain.
Augmental
Seed Round in 2023
Augmental Technologies, Inc., established in 2019 and headquartered in Boston, Massachusetts, specializes in developing innovative, hands-free technology that integrates with the human body. The company focuses on augmented reality and assistive technology, aiming to provide information access and assistance to users with both situational and severe motor impairments. By targeting the mouth as an unexplored interface for human-computer interaction, Augmental enables users to overcome physical and sensory limitations, enhancing autonomy and mobility, particularly for those living with upper extremity paralysis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.